相关实验视频
Updated: Jun 7, 2025

Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
抗体聚合:生物制药行业中的一个问题及其在AL Amyloidosis疾病中的作用
Kate Sheehan1,2, Hyesoo Jeon1,3, Sinéad C Corr2,4
1Trinity Biomedical Sciences Institute (TBSI), School of Biochemistry & Immunology, Trinity College Dublin, The University of Dublin, Dublin 2, Ireland.
了解治疗抗体中的蛋白质聚合和AL氨基粉症揭示了共同的机制. 对这些过程的洞察力可以带来改进的抗体疗法和粉样性粉症的新疗法.
科学领域:
- 生物化学 生物化学
- 蛋白质科学 蛋白质科学
- 药物开发 药物开发
背景情况:
- 治疗性抗体市场的增长需要了解蛋白质聚合.
- 聚合会影响抗体的有效性,度和安全性.
- 像低pH值,结和暴露于光线这样的条件会诱导抗体聚合.
研究的目的:
- 探索治疗抗体和AL氨基粉症中蛋白质聚合的共同原则.
- 确定潜在的新策略来管理抗体聚合和氨基粉症.
主要方法:
- 关于抗体聚合和AL氨基粉症的现有文献的审查.
- 对蛋白质错误折叠和寡合化途径的分析.
- 在治疗性蛋白质和疾病状态中的聚合机制的比较.
主要成果:
- 抗体聚合受到生产/储存条件的影响,可以通过辅助剂,突变和糖基工程来减轻.
- AL粉样性粉症涉及错误折叠的免疫球蛋白轻链的聚合,随着诊断和治疗方法的发展.
- 这两种现象都源于蛋白质通过寡合化寻求更低的自由能量状态.
结论:
- 在治疗抗体不稳定性和AL氨基粉症病原体之间存在共同的聚合原则.
- 了解这些共同的机制可以推动抗体稳定和粉样症治疗方面的创新.
- 这一研究领域对行业和临床实践都具有重大未来意义.
更多相关视频
15:23Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
Published on: May 13, 2010
10:04Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
Published on: October 20, 2017
相关概念视频
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Affinity and Avidity